The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.
There is a tendency to overlook the multiple factors and stakeholders that contributed to the Rx opioid crisis. This includes ...
Three independent pharmacies have filed lawsuits accusing GoodRx, which markets a prescription drug discount card, of ...
Independent pharmacies have filed 3 class action lawsuits against GoodRx Holdings and major pharmacy benefit managers (PBMs).
Verywell Health on MSN2d
GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...
Pearson Medical Technologies Introduces M:Print Bar Code Labeling Software V4 For Pharmacy Drug Supply Chain Security Act (DSCSA) Compliance ...
6don MSN
Since January 2024, pharmacists have been able to treat seven common health conditions without a prescription. The NHS have ...
Since 2022, the federal government has invested $26.1 million to help make naloxone, a medicine that blocks the effects of ...
Taste of Country on MSN2d
Jobs Lost: One of America’s Largest Pharmacy Chains Laying off 233 AmericansAll have had a tough go at it in the past couple of years, shuttering locations and facing opioid lawsuits. Now, Rite Aid ...
A prescription plan is an important part of Medicare, and there are two ways to get that coverage. There are penalties for ...
Harrow Inc. experienced a brief 20% stock drop in October but quickly recovered, showing resilience despite recent revenue channel underperformance. Read more here.
CNET on MSN16h
Which Decongestants Are Effective? Why the FDA Wants to Pull a Popular Medicine IngredientPhenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback